# Jean‐Jacques Kiladjian

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jean-jacques-kiladjian/

## Facts

| Field | Value |
| --- | --- |
| Citations | 28,595 |
| Field | Myeloproliferative Neoplasms: Diagnosis and Treatment |
| h-index | 70 |
| i10-index | 267 |
| Last Known Institution | Délégation Paris 5 |
| OpenAlex ID | https://openalex.org/A5008609620 |
| ORCID iD | https://orcid.org/0000-0002-8121-438X |
| Works | 750 |

## Researcher papers

- [Baveno VII – Renewing consensus in portal hypertension](https://scholariq.org/papers/baveno-vii-renewing-consensus-in-portal-hypertension/)
- [Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria](https://scholariq.org/papers/pegcetacoplan-versus-eculizumab-in-paroxysmal-nocturnal-hemoglobinuria/)
- [SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor–Naïve Patients With Myelofibrosis](https://scholariq.org/papers/simplify-1-a-phase-iii-randomized-trial-of-momelotinib-versus-ruxolitinib-in/)
- [A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis](https://scholariq.org/papers/a-pooled-analysis-of-overall-survival-in-comfort-i-and-comfort-ii-2-randomized/)

## Researcher topics

- [Myeloproliferative Neoplasms: Diagnosis and Treatment](https://scholariq.org/topics/myeloproliferative-neoplasms-diagnosis-and-treatment/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Eosinophilic Disorders and Syndromes](https://scholariq.org/topics/eosinophilic-disorders-and-syndromes/)
- [Kruppel-like factors research](https://scholariq.org/topics/kruppel-like-factors-research/)

## Researcher university

- [Délégation Paris 5](https://scholariq.org/institutions/delegation-paris-5/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.